Results 31 to 40 of about 11,054 (202)
Patient demographics before panretinal photocoagulation (at baseline).
, 2018 Patient demographics before panretinal photocoagulation (at baseline).
Masahiro Akiba (724431) +7 more
core +1 more source
Entonox as an analgesic agent during panretinal photocoagulation [PDF]
British Journal of Ophthalmology, 2002 Panretinal photocoagulation (PRP) reduces the risk of visual loss in proliferative diabetic retinopathy but some patients cannot tolerate PRP because of pain. Inhaled Entonox was evaluated as an analgesic during PRP.A randomised, crossover, double masked pilot study was performed. Patients inhaled either air or Entonox and half the PRP was applied. The
H L, Cook +5 more
openaire +2 more sources
PASCAL laser platform produces less pain responses compared to conventional laser system during the panretinal photocoagulation: a randomized clinical trial [PDF]
, 2018 Background: Most of patients experience pain during the panretinal photocoagulation(PRP). Laser photocoagulation delivery has advanced with the introduction of pattern-scanning laser systems (PASCAL). Shorter pulse duration and less choroidal penetration
Polat, Onur +4 more
core +1 more source
Journal of the College of Physicians and Surgeons Pakistan, 2018 To compare panretinal photocoagulation (PRP) plus intravitreal bevacizumab (IVB) against PRP alone in the treatment of proliferative diabetic retinopathy (PDR) in terms of mean change in best corrected visual acuity (BCVA), neovessels on disc (NVD) and neovessels elsewhere (NVE).Experimental study.Department of Ophthalmology, Benazir Bhutto Hospital ...
Warda, Ali +2 more
openaire +2 more sources
Frontiers in Medicine, 2023 ObjectiveThe objective of the study was to investigate the effectiveness of aflibercept and panretinal photocoagulation (PRP) in the treatment of proliferative diabetic retinopathy (PDR).MethodsA retrospective analysis was performed on 59 patients (59 ...
Hui Zhao +8 more
doaj +1 more source
Acta Ophthalmologica, EarlyView.Abstract Introduction The increasing number of patients with diabetes has increased the incidence of diabetic macular oedema (DME) with the accompanying risk of developing visual loss. The purpose of the present study was to describe the contributions of increased central retinal thickness (CRT) and other risk factors to the reduction in visual acuity ...
Signe Krejberg Jeppesen, Toke Bek
wiley +1 more source
Journal of Current Ophthalmology, 2019 Purpose: To evaluate the optical coherence tomography angiography (OCTA) parameters in patients with diabetic retinopathy following panretinal photocoagulation (PRP).
Ahmad Mirshahi +5 more
doaj +1 more source
Longitudinal progression of retinal nonperfusion in clinically stable diabetic retinopathy
Acta Ophthalmologica, EarlyView.Abstract Purpose To longitudinally assess and quantify changes in retinal nonperfusion (NP) in clinically stable diabetic retinopathy (DR) using ultra‐widefield fluorescein angiography (UWF‐FA) and optical coherence tomography angiography (OCTA). Methods Fifty‐one eyes from thirty‐three patients were followed for a mean of 15.9 ± 11.4 months.
Stela Vujosevic +8 more
wiley +1 more source
Flow parameter changes before and after panretinal photocoagulation in all segmental vessels.
, 2018 Flow parameter changes before and after panretinal photocoagulation in all segmental vessels.
Masahiro Akiba (724431) +7 more
core +1 more source
, 2021 The argument on the optimal treatment for patients with proliferative diabetic retinopathy (PDR) remains to be resolved. Therefore, the primary objective of the present study was to evaluate the clinical efficacy of anti-vascular endothelial growth ...
Ruibin Wu
core +1 more source